$PDEX
PRO DEX INC

2024 Q2 Form 10-Q Financial Statement

#000107997324000639 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $15.03M $14.29M $13.08M
YoY Change 41.21% 9.28% 41.17%
Cost Of Revenue $10.94M $10.29M $9.268M
YoY Change 50.22% 11.04% 44.65%
Gross Profit $4.089M $4.002M $3.811M
YoY Change 21.7% 5.01% 33.34%
Gross Profit Margin 27.21% 28.0% 29.14%
Selling, General & Admin $902.0K $1.029M $1.033M
YoY Change -14.1% -0.39% -11.33%
% of Gross Profit 22.06% 25.71% 27.11%
Research & Development $836.0K $760.0K $713.0K
YoY Change 19.43% 6.59% 8.36%
% of Gross Profit 20.45% 18.99% 18.71%
Depreciation & Amortization $306.0K $23.00K $210.0K
YoY Change 13.33% -89.05% 16.67%
% of Gross Profit 7.48% 0.57% 5.51%
Operating Expenses $1.738M $1.789M $1.746M
YoY Change -0.69% 2.46% -4.95%
Operating Profit $2.351M $2.213M $2.065M
YoY Change 46.02% 7.17% 102.25%
Interest Expense -$421.0K $138.0K $131.0K
YoY Change -111.76% 5.34% -133.85%
% of Operating Profit -17.91% 6.24% 6.34%
Other Income/Expense, Net $122.0K
YoY Change -152.59%
Pretax Income $1.930M $913.0K $1.768M
YoY Change -62.81% -48.36% 178.86%
Income Tax $343.0K $258.0K $455.0K
% Of Pretax Income 17.77% 28.26% 25.74%
Net Earnings $1.587M $655.0K $1.313M
YoY Change -58.35% -50.11% 184.2%
Net Earnings / Revenue 10.56% 4.58% 10.04%
Basic Earnings Per Share $0.19 $0.37
Diluted Earnings Per Share $0.46 $0.19 $0.36
COMMON SHARES
Basic Shares Outstanding 3.419M shares 3.511M shares 3.544M shares
Diluted Shares Outstanding 3.524K shares 3.623M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.411M $9.339M $4.771M
YoY Change -27.44% 95.75% -19.0%
Cash & Equivalents $2.631M $3.219M $2.088M
Short-Term Investments $5.780M $6.120M $2.683M
Other Short-Term Assets $607.0K $1.403M $1.919M
YoY Change -23.16% -26.89% 15.39%
Inventory $15.27M $14.24M $15.15M
Prepaid Expenses $345.0K
Receivables $13.89M $12.52M $10.57M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $36.61M $35.96M $31.15M
YoY Change 18.18% 15.45% 10.84%
LONG-TERM ASSETS
Property, Plant & Equipment $5.024M $5.191M $5.162M
YoY Change -1.08% 0.56% -61.3%
Goodwill
YoY Change
Intangibles $54.00K $61.00K $87.00K
YoY Change -33.33% -29.89%
Long-Term Investments $1.563M $1.543M $1.534M
YoY Change -79.22% 0.59% -13.72%
Other Assets $42.00K $42.00K $42.00K
YoY Change 0.0% 0.0% -91.68%
Total Long-Term Assets $15.87M $14.59M $15.83M
YoY Change -23.88% -7.83% 0.29%
TOTAL ASSETS
Total Short-Term Assets $36.61M $35.96M $31.15M
Total Long-Term Assets $15.87M $14.59M $15.83M
Total Assets $52.48M $50.55M $46.98M
YoY Change 1.26% 7.61% 7.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.513M $3.435M $3.068M
YoY Change 99.6% 11.96% -13.16%
Accrued Expenses $3.359M $2.701M $2.425M
YoY Change 7.15% 11.38% 46.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.374M $3.858M $3.114M
YoY Change 14.2% 23.89% 89.65%
Total Short-Term Liabilities $12.89M $10.42M $10.14M
YoY Change 33.24% 2.71% 31.35%
LONG-TERM LIABILITIES
Long-Term Debt $7.536M $7.884M $9.247M
YoY Change -15.42% -14.74% -12.56%
Other Long-Term Liabilities $1.182M $1.299M $1.745M
YoY Change -27.93% -25.56% -47.36%
Total Long-Term Liabilities $8.718M $9.191M $10.99M
YoY Change -17.42% -16.38% -20.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.89M $10.42M $10.14M
Total Long-Term Liabilities $8.718M $9.191M $10.99M
Total Liabilities $21.61M $19.61M $21.14M
YoY Change 6.81% -7.22% -2.21%
SHAREHOLDERS EQUITY
Retained Earnings $26.95M $25.36M $19.25M
YoY Change 8.57% 31.73% 21.0%
Common Stock $3.917M $5.575M $6.585M
YoY Change -42.12% -15.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.87M $30.94M $25.84M
YoY Change
Total Liabilities & Shareholders Equity $52.48M $50.55M $46.98M
YoY Change 1.26% 7.61% 7.04%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $1.587M $655.0K $1.313M
YoY Change -58.35% -50.11% 184.2%
Depreciation, Depletion And Amortization $306.0K $23.00K $210.0K
YoY Change 13.33% -89.05% 16.67%
Cash From Operating Activities $1.020M $4.077M $2.338M
YoY Change 64.52% 74.38% 997.65%
INVESTING ACTIVITIES
Capital Expenditures $107.0K $117.0K $135.0K
YoY Change -28.67% -13.33% -168.18%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$107.0K -$117.0K -$135.0K
YoY Change -33.12% -13.33% -34.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.501M -2.030M -497.0K
YoY Change -505.68% 308.45% -0.2%
NET CHANGE
Cash From Operating Activities 1.020M 4.077M 2.338M
Cash From Investing Activities -107.0K -117.0K -135.0K
Cash From Financing Activities -1.501M -2.030M -497.0K
Net Change In Cash -588.0K 1.930M 1.706M
YoY Change -170.84% 13.13% -447.45%
FREE CASH FLOW
Cash From Operating Activities $1.020M $4.077M $2.338M
Capital Expenditures $107.0K $117.0K $135.0K
Free Cash Flow $913.0K $3.960M $2.203M
YoY Change 94.26% 79.75% 436.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-14942
dei Entity Registrant Name
EntityRegistrantName
PRO-DEX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1261240
dei Entity Address Address Line1
EntityAddressAddressLine1
2361 McGaw Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
769-3200
dei Security12b Title
Security12bTitle
Common Stock, no par value
dei Trading Symbol
TradingSymbol
PDEX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3419089 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3219000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2936000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
4577000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
1134000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12516000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9952000 usd
CY2024Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
331000 usd
CY2023Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
494000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
14242000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
16167000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1072000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
296000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
35957000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
30979000 usd
CY2024Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6179000 usd
CY2023Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6249000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5191000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5079000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1575000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1872000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
61000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
81000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
1543000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42000 usd
CY2024Q1 us-gaap Assets
Assets
50548000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3435000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2701000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
35000 usd
CY2023Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
390000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
453000 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3858000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10419000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1299000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
7884000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
8911000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
9191000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10557000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
19610000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
20233000 usd
CY2023Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3451423 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3451423 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3545309 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3545309 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
5575000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
6767000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25363000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
24823000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
30938000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31590000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50548000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51823000 usd
CY2024Q1 us-gaap Revenues
Revenues
14293000 usd
CY2023Q1 us-gaap Revenues
Revenues
13079000 usd
us-gaap Revenues
Revenues
38819000 usd
us-gaap Revenues
Revenues
35448000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
10291000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
9268000 usd
us-gaap Cost Of Revenue
CostOfRevenue
28357000 usd
us-gaap Cost Of Revenue
CostOfRevenue
26058000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
4002000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
3811000 usd
us-gaap Gross Profit
GrossProfit
10462000 usd
us-gaap Gross Profit
GrossProfit
9390000 usd
CY2024Q1 us-gaap Selling Expense
SellingExpense
17000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
24000 usd
us-gaap Selling Expense
SellingExpense
79000 usd
us-gaap Selling Expense
SellingExpense
146000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1012000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1009000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3208000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
760000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2109000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1746000 usd
us-gaap Operating Expenses
OperatingExpenses
5640000 usd
us-gaap Operating Expenses
OperatingExpenses
5238000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2213000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2065000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4822000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4152000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
138000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
131000 usd
us-gaap Interest Expense
InterestExpense
409000 usd
us-gaap Interest Expense
InterestExpense
389000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1192000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
242000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3785000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3407000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
30000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
11000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
76000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
235000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 usd
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
7000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
913000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2187000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
704000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7412000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
258000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
570000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
164000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1840000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
655000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1617000 usd
us-gaap Net Income Loss
NetIncomeLoss
540000 usd
us-gaap Net Income Loss
NetIncomeLoss
5572000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3451 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3548 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3531 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3580 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3524 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3623 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3604 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3656 shares
CY2024Q1 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3451 shares
CY2023Q1 us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3545 shares
us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3451 shares
us-gaap Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted
WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted
3545 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31590000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
655000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1617000 usd
us-gaap Net Income Loss
NetIncomeLoss
540000 usd
us-gaap Net Income Loss
NetIncomeLoss
5572000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
30938000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
29906000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
30938000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
29906000 usd
us-gaap Profit Loss
ProfitLoss
540000 usd
us-gaap Profit Loss
ProfitLoss
5572000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
854000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
594000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
6000 usd
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-8000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
588000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
584000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3785000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3407000 usd
pdex Noncash Straightline Lease Amortization
NoncashStraightlineLeaseAmortization
-12000 usd
pdex Noncash Straightline Lease Amortization
NoncashStraightlineLeaseAmortization
-1000 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
-0 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
7000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
905000 usd
pdex Bad Debt Expense
BadDebtExpense
-1000 usd
pdex Bad Debt Expense
BadDebtExpense
-2000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2565000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4817000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-163000 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-431000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1925000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2467000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
776000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1129000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
710000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1047000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
35000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-956000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-63000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
936000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5179000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4835000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1250000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
876000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
822000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
89000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2126000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-733000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1830000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1547000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
50000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
89000 usd
pdex Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock
PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock
0 usd
pdex Payment Of Employee Payroll Taxes On Net Issuance Of Common Stock
PaymentOfEmployeePayrollTaxesOnNetIssuanceOfCommonStock
-223000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3584000 usd
pdex Principal Payments On Notes Payable And Revolving Loan
PrincipalPaymentsOnNotesPayableAndRevolvingLoan
2990000 usd
pdex Principal Payments On Notes Payable And Revolving Loan
PrincipalPaymentsOnNotesPayableAndRevolvingLoan
4766000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2770000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2863000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
283000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1239000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2936000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
849000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3219000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2088000 usd
us-gaap Interest Paid Net
InterestPaidNet
409000 usd
us-gaap Interest Paid Net
InterestPaidNet
384000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
980000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1107000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
242000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
122000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2187000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
570000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1617000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3407000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3260000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7412000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1840000 usd
us-gaap Net Income Loss
NetIncomeLoss
5572000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80B_eus-gaap--NatureOfOperations_zGkV79RIL25d" style="font: 10pt Times New Roman, Times, Serif; margin: 7.6pt 0 10pt; text-align: justify; text-indent: 0in"><b>NOTE 2. <span id="xdx_823_zHNVzDs4ZL8a">DESCRIPTION OF BUSINESS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adaptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The condensed consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q1 pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
234000 usd
CY2023Q1 pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
970000 usd
pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
762000 usd
pdex Overtime Revenue Recognition
OvertimeRevenueRecognition
2361000 usd
CY2024Q1 pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
14059000 usd
CY2023Q1 pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
12109000 usd
pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
38057000 usd
pdex Pointintime Revenue Recognition
PointintimeRevenueRecognition
33087000 usd
CY2024Q1 us-gaap Revenues
Revenues
14293000 usd
CY2023Q1 us-gaap Revenues
Revenues
13079000 usd
us-gaap Revenues
Revenues
38819000 usd
us-gaap Revenues
Revenues
35448000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
0 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
405000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
956000 usd
CY2024Q1 us-gaap Deferred Revenue
DeferredRevenue
35000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
412000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
877000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
494000 usd
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
710000 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
106000 usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
362000 usd
us-gaap Accretion Expense
AccretionExpense
376000 usd
us-gaap Accretion Expense
AccretionExpense
1108000 usd
CY2024Q1 pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
179000 usd
CY2023Q1 pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
935000 usd
pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
505000 usd
pdex Amounts Reclassified To Cost Of Sales
AmountsReclassifiedToCostOfSales
1497000 usd
CY2024Q1 pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
8000 usd
CY2023Q1 pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
25000 usd
pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
34000 usd
pdex Amounts Allocated To Discounts For Standalone Selling Price
AmountsAllocatedToDiscountsForStandaloneSellingPrice
42000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
331000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
279000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
331000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
279000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
851000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1013000 usd
CY2024Q1 us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
225000 usd
CY2023Q1 us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
41000 usd
us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
267000 usd
us-gaap Proceeds From Customers For Progress Payments
ProceedsFromCustomersForProgressPayments
741000 usd
CY2024Q1 pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
190000 usd
CY2023Q1 pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
835000 usd
pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
232000 usd
pdex Amounts Reclassified To Revenue
AmountsReclassifiedToRevenue
1697000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
35000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
35000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57000 usd
CY2023Q2 pdex Accumulated Depreciation
AccumulatedDepreciation
250000 usd
CY2024Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6179000 usd
CY2023Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
6249000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
23000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
23000 usd
us-gaap Depreciation
Depreciation
70000 usd
us-gaap Depreciation
Depreciation
70000 usd
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6383000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
8824000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
3944000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3686000 usd
CY2024Q1 pdex Inventory Sub Assemblies
InventorySubAssemblies
2379000 usd
CY2023Q2 pdex Inventory Sub Assemblies
InventorySubAssemblies
2387000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1536000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1270000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
14242000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
16167000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
4577000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
1134000 usd
CY2024Q1 pdex Marketable Securities Warrant Non Current
MarketableSecuritiesWarrantNonCurrent
0 usd
CY2023Q2 pdex Marketable Securities Warrant Non Current
MarketableSecuritiesWarrantNonCurrent
6160000 usd
CY2024Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1543000 usd
CY2023Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
1361000 usd
CY2024Q1 us-gaap Marketable Securities
MarketableSecurities
6120000 usd
CY2023Q2 us-gaap Marketable Securities
MarketableSecurities
8655000 usd
CY2024Q1 pdex Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
3964000 usd
CY2023Q2 pdex Available For Sale Securities Amortized Costs
AvailableForSaleSecuritiesAmortizedCosts
2714000 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2200000 usd
pdex Marketable Securities Unrealized Gain
MarketableSecuritiesUnrealizedGain
2400000 usd
pdex Marketable Securities Unrealized Loss
MarketableSecuritiesUnrealizedLoss
253000 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
219000 usd
CY2023 pdex Marketable Securities Unrealized Loss
MarketableSecuritiesUnrealizedLoss
286000 usd
CY2023 pdex Marketable Securities Unrealized Gain
MarketableSecuritiesUnrealizedGain
67000 usd
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1000000 usd
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1100000 usd
CY2023Q4 us-gaap Cash
Cash
1250000 usd
CY2023Q4 pdex Common Stock Shares
CommonStockShares
1828551 shares
pdex Exercise Unrealized Loss Investment
ExerciseUnrealizedLossInvestment
38000 usd
CY2024Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
6499000 usd
CY2023Q2 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
6499000 usd
CY2024Q1 pdex Accumulated Depreciation
AccumulatedDepreciation
320000 usd
CY2024Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
208000 usd
CY2023Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
208000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
147000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
127000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
61000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
81000 usd
CY2024Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
10000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
21000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
31000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
28000 usd
pdex Product Warranty Reserve
ProductWarrantyReserve
273000 usd
CY2023 pdex Product Warranty Reserve
ProductWarrantyReserve
200000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
194000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
344000 usd
CY2024Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
102000 usd
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
26000 usd
CY2024Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-103000 usd
CY2024Q1 pdex Product Warranty Accrual Amortization
ProductWarrantyAccrualAmortization
23000 usd
CY2023Q1 pdex Product Warranty Accrual Amortization
ProductWarrantyAccrualAmortization
15000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
273000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
252000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
200000 usd
CY2022Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
340000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
155000 usd
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
135000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
7000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-89000 usd
pdex Product Warranty Accrual Amortization
ProductWarrantyAccrualAmortization
89000 usd
pdex Product Warranty Accrual Amortization
ProductWarrantyAccrualAmortization
134000 usd
CY2024Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
273000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
252000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
655000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1617000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
540000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5572000 usd
CY2024Q1 pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3451 shares
CY2023Q1 pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3548 shares
pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3531 shares
pdex Weightedaverage Shares Outstanding Basic
WeightedaverageSharesOutstandingBasic
3580 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.56
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
655000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1617000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
540000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
5572000 usd
CY2024Q1 pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3451 shares
CY2023Q1 pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3548 shares
pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3531 shares
pdex Weightedaverage Shares Outstanding Diluted
WeightedaverageSharesOutstandingDiluted
3580 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
73 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
75 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
73 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
76 shares
CY2024Q1 pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3524 shares
CY2023Q1 pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3623 shares
pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3604 shares
pdex Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share
WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare
3656 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
69000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
59000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y2M23D
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
445000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
130000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
535000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
551000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
567000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
143000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1926000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
181000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1745000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0553 pure
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
143000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
425000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
139000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
418000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-000639-index-headers.html Edgar Link pending
0001079973-24-000639-index.html Edgar Link pending
0001079973-24-000639.txt Edgar Link pending
0001079973-24-000639-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pdex-20240331.xsd Edgar Link pending
pdex_10q-033124.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
pdex-20240331_cal.xml Edgar Link unprocessable
pdex-20240331_def.xml Edgar Link unprocessable
pdex-20240331_pre.xml Edgar Link unprocessable
pdex_10q-033124_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pdex-20240331_lab.xml Edgar Link unprocessable